Meneses Karen Dow, McNees M Patrick
College of Nursing, University of Central Florida, Orlando, Florida 38216, USA.
Ostomy Wound Manage. 2007 May;53(5):16-29.
Upper extremity lymphedema - a common, poorly understood, and relatively understudied complication of cancer therapy - is a progressive and debilitating condition for which no cure is available. While advances in cancer treatment have lowered the incidence of lymphedema, lymph node trauma is often inevitable and the number of cancer survivors and elderly are increasing. A review of the literature suggests that research is needed to better understand the incidence and magnitude of upper extremity lymphedema; develop reliable and valid lymphedema risk assessment instruments; improve collaborative research efforts among skin, wound, and cancer investigators; and develop evidence-based lymphedema prevention and treatment protocols. Currently available evidence also indicates that increased clinician and patient awareness and education may help reduce the risk of lymphedema-associated complications through early detection and prompt interventions.
上肢淋巴水肿——癌症治疗中一种常见、了解甚少且相对研究不足的并发症——是一种渐进性且使人衰弱的疾病,目前尚无治愈方法。虽然癌症治疗的进展降低了淋巴水肿的发病率,但淋巴结创伤往往不可避免,而且癌症幸存者和老年人的数量在不断增加。文献综述表明,需要开展研究以更好地了解上肢淋巴水肿的发病率和严重程度;开发可靠且有效的淋巴水肿风险评估工具;加强皮肤、伤口和癌症研究人员之间的合作研究;并制定基于证据的淋巴水肿预防和治疗方案。现有证据还表明,提高临床医生和患者的认识及教育水平,可能有助于通过早期发现和及时干预降低淋巴水肿相关并发症的风险。